Evidence map›Paper›PMID 19027323›Full record

ArticleJournal of the American Society for Mass Spectrometry2009

Improved infrared multiphoton dissociation of peptides through N-terminal phosphonite derivatization.

Lisa A Vasicek, Jeffrey J Wilson, Jennifer S Brodbelt

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. SITS Derivatization of Peptides to Enhance 266 nm Ultraviolet Photodissociation (UVPD).Journal of the American Society for Mass Spectrometry · 2017
    Article
  3. Article
  4. Review
  5. Implementing photodissociation in an Orbitrap mass spectrometer.Journal of the American Society for Mass Spectrometry · 2011
    Article
  6. Shedding light on the frontier of photodissociation.Journal of the American Society for Mass Spectrometry · 2011
    Article
  7. Ultraviolet photodissociation of carboxylate-derivatized peptides in a quadrupole ion trap.Journal of the American Society for Mass Spectrometry · 2011
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lisa A VasicekDepartment of Chemistry and Biochemistry, The University of Texas at Austin, Austin, Texas 78712, USA.
Jeffrey J Wilson
Jennifer S Brodbelt

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A strategy for improving the sequencing of peptides by infrared multiphoton dissociation (IRMPD) in a linear ion trap mass spectrometer is described. We have developed an N-terminal derivatization reagent, 4-methylphosphonophenylisothiocyanate (PPITC), which allows the attachment of an IR-chromogenic phosphonite group to the N-terminus of peptides, thus enhancing their IRMPD efficiencies. After the facile derivatization process, the PPITC-modified peptides require shorter irradiation times for efficient IRMPD and yield extensive series of y ions, including those of low m/z that are not detected upon traditional CID. The resulting IRMPD mass spectra afford more complete sequence coverage for both model peptides and tryptic peptides from cytochrome c. We compare the effectiveness of this derivatization/IRMPD approach to that of a common N-terminal sulfonation reaction that utilizes 4-sulfophenylisothiocyanate (SPITC) in conjunction with CID and IRMPD.

Indexed as

BenzenesulfonatesIsothiocyanatesMass SpectrometryOrganophosphonatesPeptidesSequence Analysis, ProteinThiocyanates4-isothiocyanatobenzenesulfonate4-methylphosphonophenylisothiocyanateBenzenesulfonatesIsothiocyanatesOrganophosphonatesPeptidesThiocyanates

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.